| Description | Attaching the copy contract for the manufacture of scarlatina antitoxin; he thinks they should take the attitude that the provisions of the Therapeutic Substances Act, 1925 override stipulations laid down by commercial companies and patentees. Endorsed with reply from Carnwath dated 20 December. He fears that recognition of the Dick patent will lead to further attempts to protect processes currently in the general body of knowledge |